These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 27529322)
1. Dexmedetomidine-Induced Neuroapoptosis Is Dependent on Its Cumulative Dose. Liu JR; Yuki K; Baek C; Han XH; Soriano SG Anesth Analg; 2016 Oct; 123(4):1008-17. PubMed ID: 27529322 [TBL] [Abstract][Full Text] [Related]
2. High-Dose Dexmedetomidine Promotes Apoptosis in Fetal Rat Hippocampal Neurons. Wei Q; Chen J; Xiao F; Tu Y; Zhong Y; Xie Y Drug Des Devel Ther; 2021; 15():2433-2444. PubMed ID: 34135573 [TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice. Ning Q; Liu Z; Wang X; Zhang R; Zhang J; Yang M; Sun H; Han F; Zhao W; Zhang X Neurol Res; 2017 Apr; 39(4):357-366. PubMed ID: 28173746 [TBL] [Abstract][Full Text] [Related]
4. Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats. Liao Z; Cao D; Han X; Liu C; Peng J; Zuo Z; Wang F; Li Y Brain Res Bull; 2014 Aug; 107():69-78. PubMed ID: 25026397 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Sanders RD; Sun P; Patel S; Li M; Maze M; Ma D Acta Anaesthesiol Scand; 2010 Jul; 54(6):710-6. PubMed ID: 20003127 [TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of sub-anesthetic doses of sevoflurane and dexmedetomidine co-administration in neonatal rats. Perez-Zoghbi JF; Zhu W; Neudecker V; Grafe MR; Brambrink AM Neurotoxicology; 2020 Jul; 79():75-83. PubMed ID: 32387222 [TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain. Duan X; Li Y; Zhou C; Huang L; Dong Z Acta Anaesthesiol Scand; 2014 Oct; 58(9):1121-6. PubMed ID: 25041263 [TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine attenuates propofol-induce neuroapoptosis partly via the activation of the PI3k/Akt/GSK3β pathway in the hippocampus of neonatal rats. Lv J; Wei Y; Chen Y; Zhang X; Gong Z; Jiang Y; Gong Q; Zhou L; Wang H; Xie Y Environ Toxicol Pharmacol; 2017 Jun; 52():121-128. PubMed ID: 28411582 [TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates repeated propofol exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling disruption, and juvenile cognitive deficits in neonatal rats. Wang Y; Wu C; Han B; Xu F; Mao M; Guo X; Wang J Mol Med Rep; 2016 Jul; 14(1):769-75. PubMed ID: 27222147 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine does not compromise neuronal viability, synaptic connectivity, learning and memory in a rodent model. Jimenez-Tellez N; Iqbal F; Pehar M; Casas-Ortiz A; Rice T; Syed NI Sci Rep; 2021 Aug; 11(1):16153. PubMed ID: 34373548 [TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway. Xiao Y; Zhou L; Tu Y; Li Y; Liang Y; Zhang X; Lv J; Zhong Y; Xie Y Neuropsychiatr Dis Treat; 2018; 14():2191-2206. PubMed ID: 30214209 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons. Liu B; Zhang H; Xu C; Yang G; Tao J; Huang J; Wu J; Duan X; Cao Y; Dong J Brain Res; 2011 Feb; 1375():59-67. PubMed ID: 21182828 [TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine pretreatment attenuates propofol‑induced neurotoxicity in neuronal cultures from the rat hippocampus. Wei Y; Hu J; Liang Y; Zhong Y; He D; Qin Y; Li L; Chen J; Xiao Q; Xie Y Mol Med Rep; 2016 Oct; 14(4):3413-20. PubMed ID: 27571870 [TBL] [Abstract][Full Text] [Related]
15. 17β-estradiol attenuates ketamine-induced neuroapoptosis and persistent cognitive deficits in the developing brain. Li J; Wang B; Wu H; Yu Y; Xue G; Hou Y Brain Res; 2014 Dec; 1593():30-9. PubMed ID: 25234726 [TBL] [Abstract][Full Text] [Related]
16. Noxious stimulation attenuates ketamine-induced neuroapoptosis in the developing rat brain. Liu JR; Liu Q; Li J; Baek C; Han XH; Athiraman U; Soriano SG Anesthesiology; 2012 Jul; 117(1):64-71. PubMed ID: 22617253 [TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine inhibits activation of the MAPK pathway and protects PC12 and NG108-15 cells from lidocaine-induced cytotoxicity at its maximum safe dose. Wang Q; Tan Y; Zhang N; Xu Y; Wei W; She Y; Bi X; Zhao B; Ruan X Biomed Pharmacother; 2017 Jul; 91():162-166. PubMed ID: 28463790 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models. Rajakumaraswamy N; Ma D; Hossain M; Sanders RD; Franks NP; Maze M Neurosci Lett; 2006 Dec; 409(2):128-33. PubMed ID: 17052852 [TBL] [Abstract][Full Text] [Related]
19. Effects of dexmedetomidine on the release of glial cell line-derived neurotrophic factor from rat astrocyte cells. Yan M; Dai H; Ding T; Dai A; Zhang F; Yu L; Chen G; Chen Z Neurochem Int; 2011 Apr; 58(5):549-57. PubMed ID: 21241763 [TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine promotes the recovery of neurogenesis in aged mouse with postoperative cognitive dysfunction. Wang WX; Wu Q; Liang SS; Zhang XK; Hu Q; Chen QH; Huang HJ; Xu L; Lou FQ Neurosci Lett; 2018 Jun; 677():110-116. PubMed ID: 29571823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]